© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
701594 |
As an accredited 6-Bromo-1H-Indazole-3-Carboxaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-1H-Indazole-3-Carboxaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of chemical synthesis, it’s not always easy to find compounds that lend themselves to such a wide range of creative experiments as 6-Bromo-1H-Indazole-3-Carboxaldehyde. Chemists working on targeted pharmaceuticals, agrochemical innovations, or even new materials have grown increasingly interested in indazole derivatives. This molecule combines a fused nitrogen heterocycle with a bromo substitution at the 6-position and a reactive carboxaldehyde group at the 3-position. The result is a compound that brings together both stability and reactive potential, something I’ve found incredibly valuable when looking for adaptable intermediates in multi-step syntheses.
Through years of searching for efficient routes in the lab, I’ve learned to appreciate molecules that strike a balance between reactivity and selectivity. 6-Bromo-1H-Indazole-3-Carboxaldehyde always seems to come up as a clever starting point. This compound is more than just another indazole derivative: the bromo group makes it ready for a broad spectrum of cross-coupling reactions, like Suzuki or Buchwald-Hartwig aminations, letting synthetic chemists tack on many kinds of aryl or alkyl groups. The choice of the 3-carboxaldehyde position, on the other hand, opens up a world of condensation reactions, cyclizations, and functional group transformations that many other building blocks can’t handle as reliably.
Researchers who build libraries of target molecules for pharmaceutical or agricultural screening regularly turn to indazoles because this core features prominently in kinase inhibitors and anti-inflammatory compounds. The selective bromination at the 6-position isn’t just for show: introducing a good leaving group to the aromatic system here means you can fine-tune downstream substitution patterns. The carboxaldehyde group at the 3-position provides a convenient entry point for transformations like imine, hydrazone, or oxime formation, which can alter biological activity and tune physical properties.
Comparing this compound with more basic indazoles or those without a halogen, the flexibility gained by the bromo substituent stands out. Many synthetic routes hit a dead end without a halogen handle. This molecular tweak, something that often sounds minor at first, hugely expands the landscape of possible modifications. On the other hand, other common formyl-indazole compounds might have substitutions on positions less accessible or less amenable to cross-coupling techniques. Finding an indazole that plays well with both palladium-catalyzed chemistry and direct formation of Schiff bases gives researchers real leverage, saving both time and costs at the bench.
Drug discovery thrives on the ability to rapidly explore structure-activity relationships, swapping functional groups and frameworks to hunt for new biological effects. Indazoles often show up in kinase inhibitors, antiviral agents, and experimental anticancer compounds, so it’s hardly surprising that this molecule has attracted so much attention. What stands out about 6-Bromo-1H-Indazole-3-Carboxaldehyde is how the bromine lets medicinal chemists build in modifications known to enhance metabolic stability or modulate lipophilicity, while the aldehyde group offers entry to analogs that test new hypotheses about binding pockets and activity.
Looking back at years of SAR campaigns, any intermediate that can support both aromatic substitution and aldehyde-derived transformations typically delivers more diverse chemical space from a single scaffold. Having a structure like this available means the chemist isn’t boxed in from the start, and medicinal programs can pivot to new ideas with less delay. There’s no overstating the value of keeping multiple chemical options open in fast-paced discovery environments. Unlike some substituted indazoles where the options lock you in early, this one carries the promise of true modularity.
A decent product isn’t just about the chemical structure, though: purity and batch consistency often make or break experimental research. In my own work with indazole derivatives, the difference between a product around 95% purity and one consistently above 98% can determine whether a promising lead moves forward or stalls. 6-Bromo-1H-Indazole-3-Carboxaldehyde typically arrives as a fine, off-white to pale yellow powder, with solid melting behavior and good handling properties in the lab. Its solubility in common organic solvents streamlines preparative work, giving flexibility for both small-scale and pilot-scale efforts.
In the landscape of specialty chemicals, this compound stands apart from less refined offerings by delivering batch-to-batch reliability that supports both NMR verification and scale-up. Sometimes suppliers cut corners, but the best sources invest in robust purification procedures, which becomes obvious when you spend hours troubleshooting an unexpected byproduct. The time saved from starting with a highly pure indazole far outpaces any initial cost savings from lower-grade material.
Over the years, I’ve seen 6-Bromo-1H-Indazole-3-Carboxaldehyde feature in projects ranging from hit-to-lead optimization in pharmaceuticals to advanced materials research. Its core structure helps mimic natural indazole-based scaffolds, but the variations enabled by aldehyde and bromo substituents invite a wide set of transformations. Synthetic medicinal programs gravitate toward this intermediate for assembling libraries of kinase or protease inhibitors—key targets in cancer and inflammation research—because it supports high-throughput analog development without sacrificing quality or scalability.
Recent literature points to a resurgence in interest around indazole frameworks as discovery engines for new drugs. When you dig into the details, many of the promising new molecules trace back to clever use of intermediates just like this one. In my experience, small process improvements along the way—whether in crystallization or switching solvent systems—become possible thanks to the forgiving nature of this compound’s physical properties, which isn’t always the case with more sensitive or hydrophilic derivatives. The robustness means fewer failed experiments—and less time wasted troubleshooting basic synthetic steps.
Working in a synthetic organic chemistry lab, there’s nothing more frustrating than a starting material that only works on paper. One area where 6-Bromo-1H-Indazole-3-Carboxaldehyde really shines is its amenability to a range of conditions. Need acidic condensation? The aldehyde can oblige. Pursuing Suzuki coupling? The bromo group performs well under standard Pd-catalyzed conditions. Rarely does it throw surprises in reaction screening, and it helps that the indazole core resists unwanted oxidation or decomposition routes that plague other heterocyclic aldehydes.
For those concerned about downstream processing, the product yields clean chromatographic profiles without excessive tailing. In the setting of parallel synthesis where dozens of analogues are made from a single batch, it helps streamline purification protocols—something that can save days of effort across a project timeline. The aldehyde position, positioned just right for many cyclization or ring-closure strategies, enables formation of complex, bioactive heterocycles that often prove stubborn with other starting points.
What distinguishes 6-Bromo-1H-Indazole-3-Carboxaldehyde from its siblings goes beyond the paper structure. Chemists familiar with formylated indazoles quickly notice that blocks lacking ortho-halogen substituents face more hurdles in cross-coupling and regioselective transformations. In my experience, attempts to modify indazoles without a halogen often mean more protecting group manipulations and lengthier synthesis timelines, which ties up both resources and patience. The bromo group here reduces these barriers, supporting direct coupling and late-stage diversification in a way that few other indazoles can match.
Many indazole products focus either on substitution-free cores or introduce functionality that makes downstream chemistry tricky, such as nitro or cyano groups that don’t play nicely in subsequent reductions or condensations. 6-Bromo-1H-Indazole-3-Carboxaldehyde sidesteps these issues and supports a cleaner, more straightforward toolbox—no extra workarounds needed for most research routines. This directness matches the pace of dynamical fields like pharma R&D, where agility can determine if you stay ahead or fall behind.
As bench chemists scramble to deliver promising leads, every reagent counts. Reliable access to a versatile, pure intermediate means less troubleshooting and more ambitious design work. Suppliers able to guarantee high purity batches of 6-Bromo-1H-Indazole-3-Carboxaldehyde contribute directly to the pace of research. The difference comes into play most clearly at the scale-up stage, where even a small impurity can derail a clinical candidate or slow down patent filings.
A lot of screening libraries depend on the predictability of their building blocks. Too often, side reactions or unexpected contaminants set a research project back weeks. I’ve found that indazole derivatives with careful lot verification—regular HPLC and NMR checks and well-managed storage—help prevent these setbacks. In the context of strict regulatory oversight in pharmaceuticals, clarity and documentation in the source and handling of such compounds build essential trust and streamline reporting.
The global supply chain for fine chemicals has grown complex, with manufacturers in Europe and Asia working to meet rising demand among academic and industrial researchers. Ethical sourcing of raw materials and transparent chain-of-custody documentation matters more than ever, both to comply with standards and to ensure sustainable business practices. Given its key position as a building block, 6-Bromo-1H-Indazole-3-Carboxaldehyde draws attention not just for what it does in the lab, but also in how it is made and shipped.
Buyers increasingly require clear certificates of analysis, traceability of origin, and evidence of responsible waste management during production. I’ve seen more research groups ask about the environmental impact of synthetic intermediates, especially as broader regulatory frameworks take hold in major economies. Sharing transparent information and working with partners committed to minimizing waste and optimizing production methods support both compliance and the broader good.
Arguably, the biggest obstacle facing users of advanced heterocyclic intermediates involves keeping pace with the changing regulatory and documentation landscape. Each year brings new requirements relating to substance handling, workplace exposure, and patent disclosures. Being able to produce and certify reliable stocks of 6-Bromo-1H-Indazole-3-Carboxaldehyde means keeping one step ahead of these changes, and I’ve found that close relationships with reputable suppliers smooth the way.
Another challenge involves integrating this compound into new reaction methodologies. With the rise of automated, high-throughput experimentation, the need for robust building blocks has only grown. This compound excels in standard batch processes, but its predictable thermal and solubility characteristics also favor adaptation to continuous flow synthesis or robotic setups. As labs move to greener and more controlled processes, intermediates like this one provide a cooperative starting point.
Using 6-Bromo-1H-Indazole-3-Carboxaldehyde as a launching pad, research teams can pursue even greater chemical diversity, exploring routes into complex ring systems, hybrid natural product analogs, or linker-based drug conjugates. The molecular features that make it compelling today—tunability, stability, and adaptability—also open doors to new reaction technologies, perhaps in photoredox catalysis or late-stage C–H activation.
There’s plenty of room for continuous improvement, both in how the compound is made and in how it is used. I’ve read reports of novel purification techniques and more energy-efficient synthesis routes that cut down on solvent use and hazardous waste. These process upgrades could make future production even more cost-effective and environmentally responsible. By collaborating across industry, academia, and specialty suppliers, further strides seem not just possible but likely.
To make the most of any specialty reagent, practitioners need robust, up-to-date guidance. Whether through detailed online tutorials, upskilling for young chemists, or peer-to-peer knowledge sharing, best practices continually evolve. 6-Bromo-1H-Indazole-3-Carboxaldehyde fits well in educational contexts where students and early-career scientists can see reliable, reproducible chemistry first-hand. Safe handling and mindful storage minimize risks inherent with active aldehydes or halogenated aromatics. Proper labeling, secure shelving, and knowledge of spill procedures build good habits from the outset.
In my own training days, mentorship around specialty chemicals emphasized safety, careful weighing, and methodical record-keeping. The predictability of this indazole compound, free from wild surprises, sets a positive tone for new researchers. By giving future chemists a solid foundation in reliable raw materials, the whole community benefits.
Looking across research and industrial sectors, the importance of 6-Bromo-1H-Indazole-3-Carboxaldehyde grows each year. The structural nuances—precisely placed bromine, reactive yet manageable aldehyde, robust indazole backbone—combine to create a building block with far-reaching impact. It delivers hard-to-match flexibility for both simple modifications and elaborate syntheses. In the high-stakes world of pharmaceutical discovery and advanced materials research, having trusted intermediates isn’t a luxury; it’s a baseline requirement.
Choosing the right starting materials shapes the pace and success of every project. For those working at the frontiers of synthesis, building in adaptability and reliability can mean the difference between breakthrough and stalemate. Products like 6-Bromo-1H-Indazole-3-Carboxaldehyde, developed and supplied with attention to both technical and ethical standards, illuminate the path forward. As the lab landscape evolves, this compound remains not just a tool but a partner in discovery and progress.
